Forum Markets(NASDAQ) FRMM

Market Cap$74.71M

Since IPO (2017)-100%

5 Year-100%

1 Year-81%

1 Month+6%

$5.70

-1.04%

-0.06Today

After hours$5.69-$0.01 (-0.18%)

Forum Markets last closing stock price
Metric	Price	Date
Last close	USD 5.66	2026-08-27

Forum Markets stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-3.25%	USD 5.85	2026-08-20
1 month	+6.39%	USD 5.32	2026-07-28
3 month	+27.77%	USD 4.43	2026-05-29
Year to date	+15.51%	USD 4.90	2025-12-31
1 year	-81.01%	USD 29.80	2025-08-27
3 year	-94.66%	USD 106.02	2023-08-28
5 year	-99.97%	USD 19,836.00	2021-08-27
Since inception	-99.98%	USD 36,859.99	2017-06-27

Forum Markets Financials at a Glance

Market Cap

$74.71M

Revenue (TTM)

$10.77M

Net Income (TTM)

-$527.44M

EPS (TTM)

-$33.18

P/E Ratio

-0.17

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$5.70

Volume

72,934.024

Open

$5.76

Price

$5.70

Volume

72,934.024

Open

$5.76

Previous Close

$5.66

Daily Range

$5.62 - $5.82

52-Week Range

$1.76 - $29.60

Estimated Earnings Date

Nov 12, 2026

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$5.70

Volume

72,934.024

Open

$5.76

Previous Close

$5.66

Daily Range

$5.62 - $5.82

52-Week Range

$1.76 - $29.60

Estimated Earnings Date

Nov 12, 2026

FRMM News

Why 180 Life Sciences Stock Is Falling Today

Cory RenauerAug 19, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Forum Markets

180 Life Sciences Corp. is a biotechnology company focused on researching and developing innovative therapies for inflammatory diseases. The company targets significant unmet medical needs with its main focus on anti-TNF (tumor necrosis factor) biologics, addressing conditions like Dupuytren’s contracture and frozen shoulder. Led by a team with extensive pharmaceutical expertise, 180 Life Sciences aims to advance its pipeline through clinical trials, strategic partnerships, and licensing opportunities.

Products and Services

Anti-TNF biologics targeting inflammatory diseases

Research and development of therapies for Dupuytren’s contracture

Treatment development for frozen shoulder

Expanding pipeline of novel therapeutics

What Makes 180 Life Sciences Corp. Special

180 Life Sciences Corp. distinguishes itself through its focus on unique anti-TNF biologics, which target specific inflammatory pathways. This innovative approach could reshape treatment paradigms in its target conditions, setting it apart in the biotech industry. Its experienced leadership enhances its capabilities in development and commercialization strategies.

Five Things You Need to Know

The company focuses on unmet medical needs in the inflammatory disease sector.

Its leadership comprises seasoned pharmaceutical veterans.

The anti-TNF biologics target specific inflammatory pathways, unlike traditional therapies.

Strategic growth involves clinical trials and development partnerships.

180 Life Sciences is built on leveraging intellectual property for licensing opportunities.

AI Generated • Apr 16, 2026

Industry

Biotechnology

Sector

Health Care

Employees

CEO

McAndrew A. Rudisill

Website

www.ethzilla.com

Headquarters

Palm Beach, FL 33480, US

FRMM Financials

Key Financial Metrics (TTM)

Gross Margin

82.33%

Operating Margin

-2366.40%

Net Income Margin

-4896.82%

Return on Equity

-215.13%

Return on Capital

-87.89%

Return on Assets

-331.66%

Earnings Yield

-5.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$74.71M

Shares Outstanding

13.20M

Volume

72.93K

Avg. Volume

277.94K

Financials (TTM)

Gross Profit

$8.87M

Operating Income

-$254.89M

EBITDA

-$522.20M

Operating Cash Flow

-$56.96M

Capital Expenditure

-$16.81M

Free Cash Flow

-$73.77M

Cash & ST Invst.

$4.10M

Total Debt

$25.95M

Forum Markets Performance Analysis

Forum Markets annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 6,547,000	N/A

Forum Markets sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	N/A
Q4	2025-12-31	-40.7%
Q1	2026-03-31	17.3%
Q2	2026-06-30	-52.3%

Forum Markets annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -3,871.82	57.2%
2023	2023-12-31	USD -525.87	-86.4%
2024	2024-12-31	USD -154.91	-70.5%
2025	2025-12-31	USD -55.18	-64.4%

Forum Markets sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-456.3%
Q4	2025-12-31	28.3%
Q1	2026-03-31	70.3%
Q2	2026-06-30	79.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$1.37M

N/A

Gross Profit

-$538.00K

N/A

Gross Margin

-39.41%

N/A

Market Cap

$74.71M

N/A

Market Cap/Employee

$9.34M

N/A

Employees

N/A

Net Income

-$12.82M

-642.4%

EBITDA

-$9.01M

-422.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$4.10M

+84.9%

Total Debt

$25.95M

+1737.2%

Accounts Receivable

$3.96M

+36668.4%

Inventory

$0.00

N/A

Long Term Debt

$25.95M

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-3.32%

N/A

Return on Invested Capital

-1.66%

N/A

Free Cash Flow

-$12.44M

-1000.0%

Operating Cash Flow

-$12.44M

-1000.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,719.94+0.01%

^DJIDJI

^DJIDJI$53,559.23+0.00%

^IXICNASDAQ

^IXICNASDAQ$26,447.31+0.01%

BTCBitcoin

BTCBitcoin$79,865.00+0.02%

SPCXSPCX

SPCXSPCX$140.28+0.00%

AAPLAAPL

AAPLAAPL$314.15+0.00%

AMZNAMZN

AMZNAMZN$255.22-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$227.98+0.09%

INTCIntel

INTCIntel$92.09+0.04%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.78+0.02%

ONDSOndas

ONDSOndas$8.75+0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.31+0.05%

PATHUiPath

PATHUiPath$18.33+0.09%

NOKNokia

NOKNokia$10.59+0.02%

Questions About FRMM

What is the current price of Forum Markets?

Forum Markets is trading at $5.66 per share.

What is the 52-week range for Forum Markets?

Over the past 52 weeks, Forum Markets has traded between $1.76 and $29.60.

How much debt does Forum Markets have?

As of the most recent reporting period, Forum Markets reported total debt of $25.95M.

How much cash does Forum Markets have on hand?

Forum Markets reported $4.10M in cash and cash equivalents in its most recent financial results.

What is Forum Markets’s dividend yield?

Forum Markets does not currently have a dividend yield.

Forum Markets(NASDAQ) FRMM

Forum Markets Financials at a Glance

FRMM News

Why 180 Life Sciences Stock Is Falling Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Forum Markets

Products and Services

What Makes 180 Life Sciences Corp. Special

Five Things You Need to Know

FRMM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Forum Markets Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FRMM

What is the current price of Forum Markets?

What is the 52-week range for Forum Markets?

How much debt does Forum Markets have?

How much cash does Forum Markets have on hand?

What is Forum Markets’s dividend yield?

Premium Investing Services